Transdermal NSAID Touted as an Advance Save
Reuters reports that researchers at the University of Warwick have devised a new transdermal drug delivery patch that may change the future of pain management.
The TEPI patch uses a polymer matrix in the patch as a reservoir for the drug, in this case ibuprofen. This delivery is capable of releasing 5-10 more drug than is delivered by current gel and patch analgesics. This model is capable of sustained drug delivery over a prolonged period of time.
Clinical trial data is lacking and it's not clear this will be any safer from current NSAIDs or analgesics when given via the TEPI patch. The development team is working with multiple pharmaceutical companies to use the TEPI patches in the delivery of a variety of medications. They estimate this could be commercially available within the next three years.
Continue Reading
ADD THE FIRST COMMENT
Disclosures
The author has no conflicts of interest to disclose related to this subject
If you are a health practitioner, you may Login/Register to comment.
Due to the nature of these comment forums, only health practitioners are allowed to comment at this time.